Literature DB >> 9186377

Proton-pump inhibitors: three of a kind?

D N Bateman1.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9186377     DOI: 10.1016/s0140-6736(05)62629-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Authors:  R M Martin; N R Dunn; S Freemantle; S Shakir
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

2.  Proton pump inhibitors: perspectives of patients and their GPs.

Authors:  J Grime; K Pollock; A Blenkinsopp
Journal:  Br J Gen Pract       Date:  2001-09       Impact factor: 5.386

3.  Determinants of headache in lansoprazole users in The Netherlands: results from a nested case-control study.

Authors:  Angela A M C Claessens; Eibert R Heerdink; Jacques T H M van Eijk; Cornelis B H W Lamers; Hubert G M Leufkens
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Proton pump inhibitors. Compliance with a mandated step-up program.

Authors:  M M Mamdani; K Tu; L Jaakkimainen; A Bica; J Hux
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

5.  Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.

Authors:  J N Bashford; J Norwood; S R Chapman
Journal:  BMJ       Date:  1998-08-15

6.  Appropriateness of gastric antisecretory therapy in hospital practice.

Authors:  S S Sebastian; N Kernan; A Qasim; C A O'Morain; M Buckley
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.